Gang G, Lee J, Stayman J, Tward D, Zbijewski W, Prince J, Siewerdsen J. TH-D-201B-01: Task-Based Analysis of Detectability in Tomosynthesis and Cone-Beam CT: Validation of Fourier Metrics in Comparison to Real Observers. Med Phys 2010. [DOI: 10.1118/1.3469560] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]  Open

Lee J, Martin E, Paulino G, Raybould H. Altered meal patterns in CCK1R−/− mice. Role of ghrelin receptors expressed on vagal afferents and activation of arcuate neurons. Appetite 2010. [DOI: 10.1016/j.appet.2010.04.106] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]

Oleaga L, Dalal S, Weigele J, Hurst R, Lee J, Voorhees A, Melhem E. The role of time-resolved 3D contrast-enhanced MR angiography in the assessment and grading of cerebral arteriovenous malformations. Eur J Radiol 2010;74:e117-21. [DOI: 10.1016/j.ejrad.2009.04.063] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2008] [Accepted: 04/23/2009] [Indexed: 10/20/2022]

Kim J, Kim ES, Liu D, Lee J, Solis L, Yuan P, Behrens C, Hong WK, Wistuba II, Lee H. Comprehensive analysis of expression patterns of insulin-like growth factor and Src pathway in patients with non-small cell lung cancer: Two large, independent series of tissue microarray. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.10531] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

Yoo C, Yoon S, Lee D, Suh C, Lee J, Park S, Kim D, Kim Y, Kim W, Kim S. Prognostic significance of the number of tumor (+) N2 nodes in N2 stage IIIA non-small cell lung cancer after curative resection. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.7023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

Kim K, Ryu M, Yoo C, Ryoo B, Choi D, Chang H, Lee J, Kim T, Beck M, Kang Y. Nilotinib for patients with advanced GIST who failed imatinib and sunitinib: Negative effect of prior major gastrectomy on exposure to nilotinib. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.10016] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

Zhang W, Lee J, Schiller JH, Carbone DP, Chung CH, Lenz H. Use of germline polymorphisms in VEGF to predict tumor response and progression-free survival in non-small cell lung cancer (NSCLC) patients treated with sorafenib: Subset pharmacogenetic analysis of Eastern Cooperative Oncology Group (ECOG) trial E2501. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.7607] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

Herbst RS, Blumenschein GR, Kim ES, Lee J, Tsao AS, Alden CM, Liu S, Stewart DJ, Wistuba II, Hong WK. Sorafenib treatment efficacy and KRAS biomarker status in the Biomarker-Integrated Approaches of Targeted Therapy for Lung Cancer Elimination (BATTLE) trial. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.7609] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

Choi Y, Lee J, Kim D, Ahn J, Lim S, Kim S, Hur E, Seol M, Lee K. Molecular characterization of normal karyotype acute myeloid leukemia in Korean patients. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.6592] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

Fisch M, Lee J, Chang VT, Wagner LI, Cella D, Minasian LM, McCaskill-Stevens WJ, Weiss M, Smith M, Cleeland CS. A prospective evaluation of symptom change over 4 weeks for outpatients with common solid tumors: Results from E2Z02 (the SOAPP study). J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.9120] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

William WN, Nunez M, Gu X, Jacobs RW, Litvak AM, Pickering CR, Lee J, El-Naggar AK, Glisson BS, Myers J. Prognostic value of biomarkers in tissue microarrays (TMAs) of squamous cell carcinomas of the oral tongue (SCCOT). J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.5548] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

Kumar S, Crowley J, Klein SK, Lahuerta JJ, Lee J, Moreau P, Morgan G, Richardson PG, Siegel DS, Durie BG. Treatment patterns and outcome among patients with multiple myeloma relapsing and or refractory to bortezomib and immunomodulatory drugs: A multicenter International Myeloma Working Group study. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.8125] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

Yi J, Ahn H, Lee S, Uhm J, Lee J, Park S, Park J, Park Y, Lim H, Kang W. A phase I clinical trial of S-1 in combination with sorafenib for patients with advanced hepatocellular carcinoma. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.e14655] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

Lee S, Won H, Son E, Lee J, Park S, Park J, Park Y, Lim H, Kang W. Genetic polymorphism associated with chronic neurotoxicity and recurrence in curatively-resected colon cancer patients receiving oxaliplatin-based adjuvant chemotherapy. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.3583] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

Ramalingam SS, Lee J, Belani CP, Aisner SC, Kolesar J, Howe CW, Velasco MR, Schiller JH. Cetuximab for the treatment of advanced bronchioloalveolar carcinoma (BAC): An Eastern Cooperative Oncology Group phase II study (ECOG 1504). J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.7522] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

Cho E, Ha S, Park S, Lee J, Park J, Jung S, Sym S, Shin D. Notch 1 and Notch 3 and prognosis of resected non-small cell lung cancer. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.e21089] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

Kim Y, Lee S, Choi Y, Park J, Lee J, Park Y, Ahn J, Park K, Ahn M. Molecular profiling of pulmonary pleomorphic carcinoma: Implications for targeted treatment of a rare lung malignancy. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.10576] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

Chang JY, Lippman SM, Lee J, Huang M, Wu X. Genetic variants in the telomere maintenance pathway as predictors of second primary tumors and recurrence of early-stage head and neck cancer. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.1504] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

Lee J, Jang J, Lee K, Jung C, Park J, Yoon S, Joo Y, Kim Y, Park S, Min Y. A prospective multicenter observational study for decitabine treatment in Korean patients with myelodysplastic syndrome. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.6612] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

Egloff AM, Lee J, Vaezi AE, Langer CJ, Forastiere AA, Quon H, Burtness B, Grandis JR. Tumor molecular correlates of unresectable, locally advanced head and neck squamous cell carcinoma (SCCHN) response to concurrent radiation (RT), cisplatin (DDP), and cetuximab (C225) in a phase II trial (ECOG 3303). J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.5537] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

Ahn J, Kim S, Ahn M, Lee J, Uhm J, Sun J, Park K, Park Y. Randomized phase II study of gefitinib versus erlotinib in patients with advanced non-small cell lung cancer who failed previous chemotherapy. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.7551] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

Lee J, Hirsh V, Park K, Qin S, Blajman CR, Perng R, Emerson L, Langmuir PB, Manegold C. Vandetanib versus placebo in patients with advanced non-small cell lung cancer (NSCLC) after prior therapy with an EGFR tyrosine kinase inhibitor (TKI): A randomized, double-blind phase III trial (ZEPHYR). J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.7525] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

Kim J, Hong Y, Lee J, Ryu M, Chang H, Jang S, Kim M, Yu C, Kim T. Association between deficient mismatch repair system and efficacy to irinotecan containing first-line chemotherapy in patients with sporadic metastatic colorectal cancer. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.3579] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

Kang M, Lee J, Kim T, Lee S, Park D, Seo D, Kim M. Randomized phase II trial of S-1 and cisplatin versus gemcitabine and cisplatin in advanced biliary tract adenocarcinoma. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.4029] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open

Lee J, Kim P, Liu X, Park J, Ng S, Lee T, Lim H, Singh S, Kim S, Kang W. Functional profiling of signal transduction pathway proteins in gastric cancer (GC) patients. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.e14555] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]  Open